Product Description
French maritime pine bark extract supplementation (Sourced from: https://pubmed.ncbi.nlm.nih.gov/34382717/)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: United Arab Emirates
Approved Indications: None
Known Adverse Events: None
Company: Les Derives Resiniques et Terpeniques
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Bone Diseases, Metabolic
Phase 2: Traumatic Brain Injury
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT04488653 |
19PMHD | N/A |
Unknown status |
Hypertension|Insulin Resistance|Type 2 Diabetes|Weight Gain|Overnutrition|Fatty Liver|Hyperglycemia|Down Syndrome|Obesity, Abdominal |
2021-10-19 |
2023-08-03 |
Primary Endpoints|Treatments|Trial Status |
|
NCT04141059 |
OLIGOSKIN | N/A |
Completed |
Pigmentation Disorders|Weight Gain|Blood Protein Disorders|Weight Loss |
2020-09-10 |
2022-03-03 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments|Trial Status |
|
NCT03368690 |
N201706026 | N/A |
Completed |
Attention Deficit Disorder with Hyperactivity |
2019-06-21 |
2019-09-19 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments|Trial Status |
|
NCT02063477 |
Oligo_extract | N/A |
Completed |
Hypertension |
2014-09-01 |
2022-03-01 |
Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments |
|
NCT03777683 |
NCT03777683 | P2 |
Completed |
Traumatic Brain Injury |
2019-12-22 |
2020-05-22 |
Patient Enrollment|Primary Endpoints|Treatments|Trial Status |
|
NCT03260803 |
NCT03260803 | P3 |
Completed |
Bone Diseases, Metabolic |
2018-12-01 |
2019-09-13 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments|Trial Status |